Home » COLLAGENEX PHARMACEUTICALS' ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ORACEA
COLLAGENEX PHARMACEUTICALS' ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ORACEA
CollaGenex Pharmaceuticals, Inc. announced today that a Marketing Authorization
Application (MAA) for Oracea, has been filed with the United Kingdom's Medicines
& Healthcare Products Regulatory Agency (MHRA). The UK will act as reference
member state in this decentralized procedure. The MAA for Oracea was submitted
to the MHRA on February 24, 2006. A New Drug Application for Oracea was filed
with the U.S. Food and Drug Administration in August 2005 and has been given
a PDUFA date of May 31, 2006.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May